Research Analysts Issue Forecasts for CVE:HIV Q2 Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Research analysts at Northland Capmk lifted their Q2 2026 earnings per share estimates for HIVE Blockchain Technologies in a report released on Wednesday, January 29th. Northland Capmk analyst M. Grondahl now expects that the company will post earnings of $0.07 per share for the quarter, up from their previous forecast of $0.01. Northland Capmk also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at $0.15 EPS and FY2026 earnings at $0.28 EPS.

Several other brokerages have also weighed in on HIV. Roth Capital upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Wednesday, December 18th. Keefe, Bruyette & Woods raised HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Finally, Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Tuesday, October 29th. Four research analysts have rated the stock with a strong buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies (CVE:HIV) last released its quarterly earnings data on Tuesday, November 12th. The company reported C($0.08) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C($0.12) by C$0.04. During the same period in the prior year, the firm earned ($0.39) EPS.

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.